SMALL-CELL LYMPHOMA

Clinical trials for SMALL-CELL LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new SMALL-CELL LYMPHOMA trials appear

Sign up with your email to follow new studies for SMALL-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug combo aims to control Tough-to-Treat blood cancer

Disease control Recruiting now

This study is for adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has returned or stopped responding to at least one prior treatment. The main goal is to see if a new oral drug, nemtabrutinib, combined with venetoclax, works better and is a…

Matched conditions: SMALL-CELL LYMPHOMA

Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control

Last updated Apr 01, 2026 23:11 UTC

SMALL-CELL LYMPHOMA

Get alerted when new SMALL-CELL LYMPHOMA trials appear

New drug combo aims to control Tough-to-Treat blood cancer